These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6485669)

  • 1. [Standardization of cholera vaccine and preparation of a national reference standard].
    Nenkov P; Manakhilov R; Polikar A; Karacholeva M; Genova Iu
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):55-8. PubMed ID: 6485669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potency of inactivated cholera vaccine by mouse protection assay & antibody induction method.
    Sood A; Sokhey J; Sharma SB; Gairola S; Singh S; Singh H
    Indian J Med Res; 1994 Dec; 100():262-5. PubMed ID: 7829163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar].
    Toporkov AV; Zadnova SP; Smirnova NI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):53-7. PubMed ID: 15773401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ferric ammonium citrate as virulence-enhancing agent in the toxicity test of Vibrio cholerae and the potency assay of cholera vaccine].
    Tsai MY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Feb; 22(1):75-81. PubMed ID: 2791724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of cholera vaccine potency.
    Mumford JA; Ford AW; Richer PR
    J Biol Stand; 1977; 5(4):351-67. PubMed ID: 925045
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.
    Guentzel MN; Berry LJ
    Infect Immun; 1974 Jul; 10(1):167-72. PubMed ID: 4601899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The characteristics of the protectiveness of a preparation of Vibrio cholerae outer membrane based on the data from a study using the ligated intestinal loop].
    Urbanovich LIa; Sappo SG; Kolesnik RS; Golubinskiĭ EP; Markov EIu; Ganin VS; Ivanova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):43-6. PubMed ID: 9245140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first British reference preparations of cholera vaccine (Inaba) and of cholera vaccine (Ogawa).
    Ford A; Seagroatt V
    J Biol Stand; 1977; 5(1):69-78. PubMed ID: 838751
    [No Abstract]   [Full Text] [Related]  

  • 14. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.
    Mosley WH; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A
    Bull World Health Organ; 1973; 49(4):381-7. PubMed ID: 4604478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
    Friedman H
    Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model.
    Mukherjee P; Mondal V; Bhaumik U; Sinha R; Sarkar S; Mitra S; Howlader DR; Maiti S; Mukhopadhyay AK; Dutta S; Koley H
    Microbes Infect; 2019; 21(8-9):368-376. PubMed ID: 30853357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN; Nikitina GP; Kulikova VL; Popov AA; Naumov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):70-4. PubMed ID: 6204471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.
    Preston NW
    Epidemiol Infect; 1993 Jun; 110(3):489-97. PubMed ID: 8519314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical and immunochemical characteristics of a new oral, chemical cholera bivalent vaccine and results of a trial of the preparation on volunteers].
    Dzhaparidze MN; Nikitina GP; Ivanov NR; Rystsova EA; Udalova IB
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):29-33. PubMed ID: 6760628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pasteur oral cholera vaccine: studies of reactogenicity, clinical acceptability and immunogenicity in human volunteers.
    Pitisuttitham P; Migasena S; Prayurahong B; Supanaranond W; Suntharasamai P; Supeeranan L; Chantra A; Naksrisook S
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):126-9. PubMed ID: 8362286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.